Fennec Pharmaceuticals (FENC) Misses Q1 EPS by 2c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.81 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• American Eagle Outfitters names new CFO, reaffirms 2026 guidance
• CareDx completes Naveris acquisition, adding cancer MRD testing